-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
-
Summary
-
BridgeBio Oncology Therapeutics, Inc. quarterly Common Stock, Value, Issued history and change rate from Q1 2024 to Q3 2025.
- BridgeBio Oncology Therapeutics, Inc. Common Stock, Value, Issued for the quarter ending 30 Sep 2025 was $8K.
Common Stock, Value, Issued, Quarterly (USD)